CYTH — Cyclo Therapeutics Balance Sheet
0.000.00%
HealthcareSpeculativeMicro CapSucker Stock
- $16.47m
- $12.18m
- $1.59m
Annual balance sheet for Cyclo Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1.27 | 2.22 | 2.78 | 12.8 | 16.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.093 | 0.117 | 0.182 | 0.112 | 0.539 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 1.9 | 2.77 | 3.96 | 14.1 | 19.4 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.026 | 0.019 | 0.065 | 0.088 | 0.077 |
Long Term Notes Receivable | |||||
Total Assets | 2.09 | 2.92 | 4.11 | 14.2 | 19.5 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 0.943 | 1.93 | 3.14 | 3.67 | 3.83 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.943 | 1.93 | 3.18 | 3.74 | 3.85 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1.15 | 0.993 | 0.936 | 10.5 | 15.7 |
Total Liabilities & Shareholders' Equity | 2.09 | 2.92 | 4.11 | 14.2 | 19.5 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |